American College of Emergency Physicians (ACEP) Clinical Emergency Data Registry (CEDR) Quality Measures. Status: For Public Comment- July 27, 2015

Size: px
Start display at page:

Download "American College of Emergency Physicians (ACEP) Clinical Emergency Data Registry (CEDR) Quality Measures. Status: For Public Comment- July 27, 2015"

Transcription

1 1 American College of Emergency Physicians (ACEP) Clinical Emergency Data Registry (CEDR) Quality Measures Status: For Public Comment- July 27, 2015 Obsolete after August 21, 2015

2 2 Table of Contents Disclaimer Clinical Emergency Data Registry Overview Quality Measures Technical Expert Panel Objectives & Acknowledgments Quality Measures Technical Expert Panel Roster Purpose of Measurement Set Harmonization of the Measurement Set Guide to Reading the Data Requirements Table (DRT) Measure #1: Sepsis Management: Lactate Level Measurement Accountability measure Measure #2: Sepsis Management: Blood Cultures Ordered Quality Improvement measure Measure #3: Sepsis Management: Antibiotics Ordered Accountability measure Measure #4: Sepsis Management: Fluid Resuscitation Accountability measure Measure #5: Sepsis Management: Repeat Lactate Level Measurement Accountability measure Intermediate Outcome Measure #6: Sepsis Management: Lactate Clearance Rate 10% Accountability measure Measure #7: Appropriate Foley Catheter Use in the Emergency Department Accountability measure Measure #8: Appropriate Use of Imaging for Recurrent Renal Colic Quality Improvement measure Additional Measure Recommended for Use with this Measure Set References for All Measures Page

3 3 Disclaimer Physician Performance Measures (Measures) and related data specifications developed by the American College of Emergency Physicians (ACEP) are intended to facilitate quality improvement activities by physicians. These measures are intended to assist physicians in enhancing quality of care. These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. ACEP encourages testing and evaluation of its Measures. Measures are subject to review and may be revised or rescinded at any time by ACEP. The measures may not be altered without prior written approval from ACEP. Commercial use is defined as the sale, license, or distribution of the measures for commercial gain, or incorporation of the measures into a product or service that is sold, licensed, or distributed for commercial gain. Commercial uses of the measures require a license agreement between the user and ACEP. Neither ACEP nor its members shall be responsible for any use of the measures. THESE MEASURES AND SPECIFICATIONS ARE PROVIDED AS IS WITHOUT WARRANTY OF ANY KIND. Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, PCPI, and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT ) or other coding contained in the specifications. CPT contained in the Measure specifications is copyright American Medical Association. LOINC copyright Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms (SNOMED CT ) copyright International Health Terminology Standards Development Organisation. ICD-10 copyright 2014 World Health Organization. All Rights Reserved.

4 4 Clinical Emergency Data Registry Overview The American College of Emergency Physicians (ACEP) is committed to providing the highest quality emergency care and optimizing health outcomes for all patients. In doing so, ACEP has developed the Clinical Emergency Data Registry (CEDR), which was deemed by the Center for Medicaid and Medicare Services (CMS) as a qualified clinical data registry (QCDR) for the 2015 performance year. CEDR is the first Emergency Medicine specialty-wide registry at a national level, designed to measure and report healthcare quality and outcomes. It will also provide data to identify practice patterns, trends and outcomes in emergency care. CEDR is an evolving registry, which will support emergency physicians efforts to improve quality and practice in all types of emergency departments even as practice and payment policies change over the coming years. A main objective of CEDR is to help emergency physicians and clinicians meet both the Centers for Medicare and Medicaid Services Physician Quality Reporting System (PQRS) reporting and potentially regional and national certification requirements. Finally, CEDR will provide data to identify practice patterns, trends, and outcomes in emergency care. Goals of CEDR Provide a unified method for ACEP members to collect and submit Physician Quality Reporting System (PQRS) data, Maintenance of Certification (MOC), Osteopathic Continuous Certification (OCC), Ongoing Professional Practice Evaluation (OPPE), outcome data, and other related or applicable quality and patient safety data to meet quality improvement and regulatory requirements Promote the highest quality of emergency care for patients Demonstrate the value of emergency care Facilitate appropriate emergency care research Benefits of CEDR Increased Medicare revenue (up to 6% for the 2015 performance year) Potentially increased revenue from private payers Participation can cover all quality measure reporting requirements TJC OPPE/ Focused Professional Practice Evaluation (FPPE) compliance MOC Part IV activities (in conjunction with an American Board of Emergency Medicine [ABEM] approved MOC program) and MOL activities For more information on CEDR, please visit

5 5 Quality Measures Technical Expert Panel Objectives The ACEP Board of Directors approved the development of quality measures in January 2015 with the following objectives: To develop, specify, maintain, and recommend quality measures for the Clinical Emergency Data Registry (CEDR); To continue the ongoing cyclical work of evaluating and maintaining current portfolio of CEDR accountability measures for CMS reporting programs. To identify areas for internal quality improvement through MOC Part IV, OPPE, and other QI and data collection activities for important topics. Acknowledgement This measure set was made possible in part by the generous support of the American Board of Emergency Medicine (ABEM). Quality Measures The American College of Emergency Physicians (ACEP) convened a Quality Measures Technical Expert Panel (TEP) to assess opportunities for the development of evidence-based performance measures for ACEP s Clinical Emergency Data Registry (CEDR). The ACEP Quality Measures TEP proposes this set of registry measures to promote evidence-based medicine and address gaps in care around emergency medicine with a focus on sepsis management and efficiency in the emergency department.

6 6 Quality Measures Technical Expert Panel Roster Chair Arjun Venkatesh, MD, MBA Vice-Chair Jeremiah D. Schuur, MD, MHS, FACEP Quality & Performance Committee Chair Stephen V. Cantrill, MD, FACEP Qualified Clinical Data Registry Chair Steve Epstein, MD, FACEP Board Liaison James Augustine, MD, FACEP American College of Emergency Physicians Robert I. Broida, MD, FACEP Kathleen Brown, MD, FACEP Vidor E. Friedman, MD, FACEP Michael Granovsky, MD, FACEP Timothy C. Hsu, MD, FACEP Chris Moore, MD, FACEP Michael P. Phelan, MD FACEP William E Reisinger, III, DO, FACEP Paul Sierzenski, MD, RDMS, FACEP L. Kendall Webb, MD, FACEP American College of Emergency Physicians Sepsis Expert Panel Michael Filbin, MD, FACEP David Huang, MD, MPH, FACEP Alan Jones, MD, FACEP Jack Kelly, DO, FACEP Tiffany Osborn, MD, FACEP John Rogers, MD, FACEP Todd Slesinger, MD, FACEP Scott Weingart, MD, FACEP Jessica Whittle, MD, PhD, FACEP Donald Yealy, MD, FACEP American Academy of Family Physicians Andrew Eisenberg, MD, MHA American Academy of Neurological Surgeons David Okonkwo, MD, PhD American Academy of Neurology Steven Mandel, MD, FAAN American Board of Emergency Medicine Michael L Carius, MD, FACEP Terry Kowalenko, MD, FACEP Robert Philip Wahl, MD, FACEP American College of Radiology/ American College of Neuroradiology Ari Blitz, MD Judy Burleson, MHSA (Staff) Marta Heilbrun, MD, MS Emergency Nurses Association Ann Marie Papa, DNP, RN, CEN, FAEN, FAAN The Joint Commission Kathleen Domzalski, RN, BS, MHSA

7 7 AMA-PCPI Consultants Yvette Apura, RHIA Seth Blumenthal, MBA Elizabeth Bostrom, MPH Kendra Hanley, MS Meredith Jones, MPH Jamie Jouza, MBA Toni Kaye, MPH Kimberly Smuk, RHIA Samantha Tierney, MPH ACEP Staff Dainsworth Chambers Marta Foster Victoria Purcell Margaret Montgomery Stacie Schilling Jones, MPH David McKenzie

8 8 Purpose of Measurement Set The American College of Emergency Physicians (ACEP) convened a multi-disciplinary stakeholder technical expert panel (TEP) to identify and develop quality measures for the purpose of establishing ACEP s Clinical Emergency Data Registry (CEDR). The goal of CEDR is to improve outcomes and quality of care provided to patients in the emergency department (ED). The TEP was tasked with developing registry measures that reflect the most rigorous clinical evidence and address areas most in need of performance improvement. The TEP considered opportunities for outcome, process and structural measures centered on appropriate management of sepsis and efficiency of care in the ED. The first six measures represent the critical steps and appropriate management of sepsis as detailed in the Surviving Sepsis Campaign clinical practice guidelines and include an intermediate outcome measure of the effectiveness of care provided in those critical steps. The intent of the sepsis measures is to highlight those opportunities for individual emergency department physicians to impact sepsis care. Together, the first six measures provide a broad, evidence-based view of the quality of sepsis management in the ED. For the current implementation of these measures, the aim is to focus on the completion of these critical steps during the patient s ED visit. The final two measures in the set focus on key opportunities to improve the efficiency of care provided in the ED and reduce overuse of inappropriate services. The measures in this set are intended to establish baseline performance of individual emergency department physicians. As these measures are implemented through CEDR, future iterations will be shaped by the emergency department physician performance data that is collected. Similarly, data from CEDR s base year will inform ACEP s participation in CMS group practice reporting options (GPRO) for QCDRs and opportunities to harmonize measures.

9 9 Harmonization of the Measurement Set As existing hospital-level or plan-level measures are available for the same measurement topics, attempts to harmonize the measures to the extent feasible were considered during the development process. The ACEP CEDR sepsis management measures are similar to NQF 0500: Severe Sepsis and Septic Shock: Sepsis Management Bundle and CMS IQR SEP-1: Early Management Bundle, Severe Sepsis/Septic Shock. NQF 0500 and CMS SEP-1 are specified for use at the hospital-level and the ACEP measures presented in this measurement set are for use at the provider-level. Differences in the denominator measure language and level of measurement are presented by measure steward in Table 1. Sepsis Measure s and Level of Measurement by Measure Steward. As the ACEP CEDR measures evolve based on data collected in the base year, the opportunity for harmonization and alignment with other sepsis denominators will be visited. Please see individual measure documentation for additional information regarding measure harmonization. Table 1. Sepsis Measure s and Level of Measurement by Measure Steward Measure Steward Language of Sepsis Measures Level of Measurement American College of Emergency Physicians (ACEP) Clinical Emergency Data Registry (CEDR) National Quality Forum (NQF) 0500: Severe Sepsis and Septic Shock: Sepsis Management Bundle Center for Medicare and Medicaid Services (CMS) SEP-1: Early Management Bundle, Severe Sepsis/Septic Shock All emergency department visits for patients aged 18 years and older with septic shock For purposes of this measure, patients with septic shock will be identified with any of the following criteria: Diagnosis of septic shock Diagnosis of sepsis and hypotension Diagnosis of infection and hypotension Number of patients presenting with severe sepsis or septic shock. Inpatients age 18 and over with an Principal or Other Diagnosis Code of Sepsis, Severe Sepsis, or Septic Shock Included Populations: Discharges age 18 and over with an Principal or Other Diagnosis Code of Sepsis, Severe Sepsis, or Septic Shock Eligible Provider (EP) Eligible Hospital (EH), Facility, Integrated Delivery System Eligible Hospital (EH)

10 10 Guide to Understanding the Format and Information Included in the Data Requirements Table (DRT) The purpose of the Data Requirements Table (DRT) is to identify each of the data elements that will be needed to capture the measure, including the required attributes of each data element. The DRT does not include the Boolean logic (AND, OR, AND NOT) that is used to combine the data elements to form the measure components (Initial Population,, Exclusions, Numerator, and Exceptions) based on the measure s clinical intent. Once the measures and DRTs have been finalized, then the Health Quality Measures Format (HQMF) emeasure, which includes the logic, will be developed. Definitions for each column, from left to right, included in the DRT: Measure Component Measure Component identifies where in the measure the data element is located. For proportion measures the possible options include: Initial Population,, Exclusions, Numerator or Exceptions. Supplemental Data Elements are also included in the measure component column, and applicable to all measures. The supplemental data elements include administrative sex, race, ethnicity, and payer, and are recommended to be collected for purposes of stratifying measure results. Additional information regarding the supplemental data elements can be found within the CMS Measures Management System Blueprint at: Instruments/MMS/MeasuresManagementSystemBlueprint.html Quality Data Model (QDM) Category All data elements used in quality measures are classified according to the QDM, the data model used to specify electronic clinical quality measures (ecqms). When defining a QDM element, the QDM category is the highest level of definition. There are 19 different QDM categories in the data model, including Medication, Procedure, and Diagnostic Study. Complete documentation for the Quality Data Model can be accessed at: Quality Data Model (QDM) Datatype The QDM datatype provides the context in which each category is used to describe a part of the clinical care process. Examples of the QDM datatypes include Diagnosis, Active and Procedure, Performed as they are applied to the Condition/Diagnosis/Problem and Procedure categories, respectively. Value Set Name The Value Set Name is the title of the list of clinical concepts, or codes, that are used to represent a data element used in a quality measure. Considerations and best practices for naming a value set so that it is in alignment with the intent and purpose of the data element are located at: Occurrence A is periodically used in the Value Set Name column to further define the Data Element, indicating a specific instance of that data element. Occurrence A allows a specific instance of that data element to be used across

11 11 multiple measure components in the measure, or used multiple times within the same measure component, and in order to meet the intent of the measure, it needs to be the same specific instance. Standard Terminology The Standard Terminology identifies the coding system used to specify the value set. In the DRT, only the name of the standard terminology is included; specific clinical concepts (or codes) are not included. Examples of the standard terminologies used in emeasures include, LOINC, CPT, and. The standard terminology selected to represent a value set follows the vocabulary recommendations that have been designated by the ONC Health IT Standards Committee (HITSC) for each QDM category. Both the transition vocabularies and the clinical vocabularies that were recommended by the HITSC are included in the DRT. More information about how these terminologies were selected is available at: A designation is used in this column to indicate that in addition to the individual value sets, there will be another value set that will serve as a wrapper for the individual value set(s) used to specify the data element. It groups together value sets that represent that same umbrella data element. For example, the individual value sets for Sepsis in,, and are wrapped together in a grouping value set. OID OID is an acronym used for object identifier and can be thought of as a numeric label used to represent the value set. Individual value sets and value sets all have a unique OID. Where the information included in the OID column is listed as, it means that the OID has not yet been assigned. OIDs that have been populated represent existing value sets that are currently available in the National Library of Medicine Value Set Authority Center (NLM VSAC). Constraints The Constraints column identifies the temporal operators, and the relationship between the data element being specified and another data element(s) in the measure. The temporal operators are used to connect two data elements included in the measure. Three examples of temporal operators include overlaps, starts during, and starts before end of. The QDM documentation available at includes a complete list of the available temporal operators and their corresponding definitions. Here is an example of how the temporal operators and the data element relationships are combined together and presented in the Constraints column. Data Element A starts during Data Element B. The Constraints column will include the italicized information (temporal operator and Data Element B). In instances where the term, Occurrence A is used in the Constraints column to further define Data Element B; the intent of Occurrence A is to refer to a specific instance of Data Element B.

12 12 Comments/Rationale Additional comments relevant to the data element being specified are included in the Comments/Rationale column. During public comment, we have included some specific questions in the Comments/Rationale column. We appreciate responses to the specific questions as they will inform the final specifications of the measures. How to use the information presented in the DRT to understand the intent of the data element: In general, each data element included in the DRT is represented in a single row. Should a data element have additional attributes that are to be applied to it, then an additional row will be added. This can be easily identified by the Attribute entry in the QDM Category column; a note is included in the Comments/Rationale column that names the data element to which a given attribute is applied. Example: Sepsis Sepsis is a diagnosis that will be specified using,, and standard terminologies. It is used in the initial population of the measure, and in order to meet inclusion in the initial population, the active diagnosis of Sepsis needs to start during the Emergency Department Visit.

13 13 Measure Description MEASURE #1: Sepsis Management: Lactate Level Measurement Percentage of emergency department visits for patients aged 18 years and older with septic shock who had a serum lactate level ordered during the emergency department visit Measure Components Numerator Statement Statement Exclusions Emergency department visits for patients who had a serum lactate level ordered during the emergency department visit All emergency department visits for patients aged 18 years and older with septic shock For purposes of this measure, patients with septic shock will be identified with any of the following criteria: Diagnosis of septic shock Diagnosis of sepsis and hypotension Diagnosis of infection and hypotension Patients with any of the following: Transferred into the emergency department from another acute care facility or other in-patient hospital setting Left before treatment was complete Died during the emergency department visit Cardiac arrest within the emergency department visit Patient or surrogate decision maker declined care Advanced directives present in patient medical record for comfort care Toxicological emergencies Burn Seizures Primary diagnosis of o Gastrointestinal bleeding o Stroke o Acute myocardial infarction o Acute trauma Exceptions Rationale for the Measure Supporting None As soon as patients presenting to the emergency department with sepsis- induced tissue hypoperfusion are identified, protocolized, quantitative resuscitation is recommended. Early resuscitation strategies, including evidence-based treatments to normalize elevated lactate, are associated with improved survival rates in emergency department patients. 1 In order to achieve lactate normalization in patients with elevated levels, an initial lactate measurement must be obtained. The following evidence statements are quoted verbatim from the referenced clinical

14 14 Guideline guidelines and other references: Measure Importance Relationship to Desired Outcome Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 We recommend routine screening of potentially infected seriously ill patients for severe sepsis to increase the early identification of sepsis and allow implementation of early sepsis therapy (grade 1C). 1 Surviving Sepsis Campaign 3-Hour Bundle Measure Lactate Level. Obtaining a lactate level is essential to identifying tissue hypoperfusion in patients who are not yet hypotensive but who are at risk for septic shock. 2 An association between elevated lactate with morbidity and mortality in diverse populations of critically ill patients including patients with septic shock. 3 Clinically, patients with sepsis experience elevated serum lactate due to impaired clearance or excessive production of lactate manifested by a dysfunction in the hepatic, renal, and other organ functions. For patients presenting to the emergency department with sepsis, a measurement of serum lactate is a suitable and timely strategy for confirming patients atrisk for poor outcomes and initiating treatment. 4 Opportunity for Improvement Related Measures Obtaining a lactate level is associated with improved outcomes in patients with sepsis as it is critical to identifying tissue hypoperfusion in patients who are not yet hypotensive but who are at risk for severe sepsis or septic shock. 4 In a large-scale, multicenter study of compliance with the Surviving Sepsis Campaign guidelines, only 61% of patients had an initial lactate value measured in the first quarter of the study. In the final quarter, only 78.7% of patients had an initial lactate measurement. 5 Staff has considered harmonization with CMS Hospital Inpatient Quality Reporting (IQR): Sepsis Bundle and NQF #0500: Severe Sepsis and Septic Shock Management Bundle Measure Designation Type of measure National Quality Strategy Priority/CMS Measure Domain (check all that apply) Process Outcome Structure Clinical Process-Effectiveness Patient Safety Patient Experience Care Coordination Efficiency: Overuse Efficiency: Cost Population & Community Health Level of Individual clinicians Measurement Clinician groups

15 15 (check all that apply) Additional Data Elements Hospital Outpatient/ED Additional data elements for collection in the American College of Emergency Physician s Clinical Emergency Data Registry (CEDR) are described here. These data elements include: Diagnosis of severe sepsis Diagnosis of organ dysfunction Triage start date and time Provider contact date and time Treatment space date and time Disposition order from ED date and time ICU admission date and time OR admission date and time Serum lactate measurement collection start date and time Serum lactate measurement result

16 Data Requirements Table Measure #1: Sepsis Management: Lactate Level Measurement 16 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Supplemental Data Elements Individual Characteristic Patient Characteristic ONC Administrative Sex Administrative Sex (HL7 v2.5) during measurement period Individual Characteristic Patient Characteristic Race CDC during measurement period Individual Characteristic Patient Characteristic Ethnicity CDC during measurement period Individual Characteristic Patient Characteristic Payer Source of Payment Typology during measurement period This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. Measure Timing n/a Measurement Period n/a n/a by Measure Implementer Initial Population Individual Characteristic Patient Characteristic Age Calculation n/a Measurement start date minus Birth Date must be greater than or equal to > = 18 years AT Measurement Period 18 years For the purposes of this measure, 'Emergency Department Visit' is defined Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015) Condition/Diagnosis/Problem Diagnosis, Active Infection Condition/Diagnosis/Problem Diagnosis, Active Acute Hypotension Condition/Diagnosis/Problem Diagnosis, Active Sepsis Condition/Diagnosis/Problem Diagnosis, Active Septic Shock Equals Initial Population Transfer of Care Transfer From Inpatient Facility starts before end of [Occurrence A of Encounter, Transfer of Care Transfer From Acute Care Facility starts before end of [Occurrence A of Encounter, Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period For the purposes of this measure, 'Emergency Department Visit' is defined as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015). This attribute is applied to the value set titled 'Emergency Department Visit'. This value set includes the concepts related to 'left against medical advice' and 'left before treatment completion', either with or without an intervention. Exclusions Attribute Attribute: discharge status Left Before Treatment Completion n/a - Patient left before treatment completion (LBTC) - Patient left before being seen (LBBS) - Patient left before being seen without intervention (LBBS NI) - Patient left before being seen with intervention (LBBS WI) - Patient left subsequent to being seen (LSBS) (Wiler et al. 2015) Attribute Attribute: discharge status Patient Expired n/a This attribute is applied to the value set titled 'Emergency Department Visit'. Condition/Diagnosis/Problem Diagnosis, Active Cardiac Arrest Intervention Intervention, Order Comfort Measures American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

17 Data Requirements Table Measure #1: Sepsis Management: Lactate Level Measurement 17 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Intervention Intervention, Performed Comfort Measures Communication Communication: Patient to Provider Declined Care Condition/Diagnosis/Problem Diagnosis, Active Burn We seek public comment on the appropriate population of burn patients who should be excluded from this measure. Condition/Diagnosis/Problem Diagnosis, Active Seizure Condition/Diagnosis/Problem Diagnosis, Active Toxicological Emergency This value set includes the concept of metformin toxicity. We seek public comment on what other toxicological emergencies are relevant to these measures and should be included in this value set. Exclusions Condition/Diagnosis/Problem Diagnosis, Active Gastrointestinal Bleeding Condition/Diagnosis/Problem Diagnosis, Active Stroke Condition/Diagnosis/Problem Diagnosis, Active Myocardial Infarction Condition/Diagnosis/Problem Diagnosis, Active Acute Trauma Attribute Attribute: Ordinality Principal n/a This attribute determines that a diagnosis was the principal diagnosis for the 'Emergency Department Visit' and is applied to the value sets titled 'Gastrointestinal Bleeding', 'Stroke', 'Myocardial Infarction', and 'Acute Trauma'. Numerator Laboratory Test Laboratory Test, Order Serum Lactate LOINC during [Occurrence A of Encounter, Performed: Exceptions There are no valid denominator exceptions 2015 American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

18 18 Measure Description MEASURE #2: Sepsis Management: Blood Cultures Ordered This measure is intended for Quality Improvement reporting purposes. Percentage of emergency department visits for patients aged 18 years and older with septic shock who had a blood culture ordered during the emergency department visit Measure Components Numerator Statement Statement Exclusions Emergency department visits for patients who had a blood culture ordered during the emergency department visit All emergency department visits for patients aged 18 years and older with septic shock For purposes of this measure, patients with septic shock will be identified with any of the following criteria: Diagnosis of septic shock Diagnosis of sepsis and hypotension Diagnosis of infection and hypotension Patients with any of the following: Transferred into the emergency department from acute care facility or other inpatient hospital setting Left before treatment was complete Died during the emergency department visit Cardiac arrest within the emergency department visit Patient or surrogate decision maker declined care Advanced directives present in the patient medical record for comfort care Toxicological emergencies Burn Seizures Primary diagnosis of: o Gastrointestinal bleeding o Stroke o Acute myocardial infarction o Acute trauma Exceptions Rationale for the Measure None In order to identify the origin of infection in critically ill septic shock patients, blood cultures should be ordered to guide the course and type of antibiotics used against harmful pathogens for treatment. The failure to order a blood culture during the emergency department visit may impact the appropriate identification and growth of bacteria which is associated with an increase in negative health outcomes to the patient including death.

19 19 This measure is intended for quality improvement reporting. The collection of blood cultures is a critical step in the treatment of sepsis but is not exclusively attributed to the action of the emergency department physician. Supporting Guideline The following evidence statements are quoted verbatim from the referenced clinical guidelines and other references: Measure Importance Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 We recommend routine screening of potentially infected seriously ill patients for severe sepsis to increase the early identification of sepsis and allow implementation of early sepsis therapy (grade 1C). We recommend obtaining appropriate cultures before antimicrobial therapy is initiated if such cultures do not cause significant delay (>45 minutes) in the start of antimicrobial(s) administration (grade 1C). 1 Relationship to Desired Outcome Opportunity for Improvement Related Measures Blood cultures are effective in identifying the specific infecting organism in septic shock patients and guiding the antibiotic regimen used in treatment. 2 Customization of antibiotic treatment, following the order of the blood culture, is associated with numerous benefits to the patient including reduction in exposure to: unnecessary antibiotics, drug-resistant organisms, complications with antibiotic use, allergies, and drug reactions. 1 A prospective multi-center observational study found that compliance with the Surviving Sepsis Campaign 2012 guidelines recommendation to draw blood cultures before antibiotics were administered was only in the range of 54.4 to 64.5%. 6,7 Staff has considered harmonization with CMS Hospital Inpatient Quality Reporting (IQR): Sepsis Bundle and NQF #0500: Severe Sepsis and Septic Shock Management Bundle Measure Designation Type of measure National Quality Strategy Priority/CMS Measure Domain (check all that apply) Level of Measurement Process Outcome Structure Clinical Process-Effectiveness Patient Safety Patient Experience Care Coordination Efficiency: Overuse Efficiency: Cost Population & Community Health Individual clinicians

20 20 (check all that apply) Additional Data Elements Clinician groups Hospital Outpatient/ED Additional data elements for collection in the American College of Emergency Physician s Clinical Emergency Data Registry (CEDR) are described here. These data elements include: Diagnosis of severe sepsis Diagnosis of organ dysfunction Triage start date and time Provider contact date and time Treatment space date and time Disposition order from ED date and time ICU admission date and time OR admission date and time Blood culture collection start date and time Blood culture result Blood culture ordered prior to the order of antibiotics

21 Data Requirements Table Measure #2: Sepsis Management: Blood Cultures Ordered 21 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Supplemental Data Elements Individual Characteristic Patient Characteristic ONC Administrative Sex Administrative Sex (HL7 v2.5) during measurement period Individual Characteristic Patient Characteristic Race CDC during measurement period Individual Characteristic Patient Characteristic Ethnicity CDC during measurement period Individual Characteristic Patient Characteristic Payer Source of Payment Typology during measurement period This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. Measure Timing n/a Measurement Period n/a n/a by Measure Implementer Initial Population Individual Characteristic Patient Characteristic Age Calculation n/a Measurement start date minus Birth Date must be greater than or equal to > = 18 years AT Measurement Period 18 years For the purposes of this measure, 'Emergency Department Visit' is defined Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015) Condition/Diagnosis/Problem Diagnosis, Active Infection Condition/Diagnosis/Problem Diagnosis, Active Acute Hypotension Condition/Diagnosis/Problem Diagnosis, Active Sepsis Condition/Diagnosis/Problem Diagnosis, Active Septic Shock Equals Initial Population Transfer of Care Transfer From Inpatient Facility starts before end of [Occurrence A of Encounter, Transfer of Care Transfer From Acute Care Facility starts before end of [Occurrence A of Encounter, Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period For the purposes of this measure, 'Emergency Department Visit' is defined as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015). This attribute is applied to the value set titled 'Emergency Department Visit'. This value set includes the concepts related to 'left against medical advice' and 'left before treatment completion', either with or without an intervention. Exclusions Attribute Attribute: discharge status Left Before Treatment Completion n/a Patient left before treatment completion (LBTC) - Patient left before being seen (LBBS) - Patient left before being seen without intervention (LBBS NI) - Patient left before being seen with intervention (LBBS WI) - Patient left subsequent to being seen (LSBS) (Wiler et al. 2015) Attribute Attribute: discharge status Patient Expired n/a This attribute is applied to the value set titled 'Emergency Department Visit'. Condition/Diagnosis/Problem Diagnosis, Active Cardiac Arrest Intervention Intervention, Order Comfort Measures Intervention Intervention, Performed Comfort Measures American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

22 Data Requirements Table Measure #2: Sepsis Management: Blood Cultures Ordered 22 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Communication Communication: Patient to Provider Declined Care Condition/Diagnosis/Problem Diagnosis, Active Burn We seek public comment on the appropriate population of burn patients who should be excluded from this measure. Condition/Diagnosis/Problem Diagnosis, Active Seizure Condition/Diagnosis/Problem Diagnosis, Active Toxicological Emergency This value set includes the concept of metformin toxicity. We seek public comment on what other toxicological emergencies are relevant to these measures and should be included in this value set. Exclusions Condition/Diagnosis/Problem Diagnosis, Active Gastrointestinal Bleeding Condition/Diagnosis/Problem Diagnosis, Active Stroke Condition/Diagnosis/Problem Diagnosis, Active Myocardial Infarction Condition/Diagnosis/Problem Diagnosis, Active Acute Trauma Attribute Attribute: Ordinality Principal n/a This attribute determines that a diagnosis was the principal diagnosis for the 'Emergency Department Visit' and is applied to the value sets titled 'Gastrointestinal Bleeding', 'Stroke', 'Myocardial Infarction', and 'Acute Trauma'. Numerator Laboratory Test Laboratory Test, Order Blood Culture LOINC during [Occurrence A of Encounter, Performed: Exceptions There are no valid denominator exceptions 2015 American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

23 23 MEASURE #3: Sepsis Management: Antibiotics Ordered Measure Description Percentage of emergency department visits for patients aged 18 years and older with septic shock who had an order for antibiotics during the emergency department visit Measure Components Numerator Statement Statement Exclusions Emergency department visits for patients who had an order for antibiotics during the emergency department visit All emergency department visits for patients aged 18 years and older with septic shock For purposes of this measure, patients with septic shock will be identified with any of the following criteria: Diagnosis of septic shock Diagnosis of sepsis and hypotension Diagnosis of infection and hypotension Patients with any of the following: Transferred into the emergency department from another acute care facility or other in-patient hospital setting Left before treatment was complete Died during the emergency department visit Cardiac arrest within the emergency department visit Patient or surrogate decision maker declined care Advanced directives present in patient medical record for comfort care Toxicological emergencies Burn Seizures Primary diagnosis of: o Gastrointestinal bleeding o Stroke o Acute myocardial infarction o Acute trauma Exceptions Rationale for the Measure Supporting Guideline None The emergency physician should order antibiotics for patients with septic shock in order to ameliorate patient decline. Delay in delivery of antibiotics in the emergency department puts the patient at high-risk for adverse outcomes such as drug reactions, increase length of hospital stay, and mortality. The following evidence statements are quoted verbatim from the referenced clinical guidelines and other references:

24 24 Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 The administration of effective intravenous antimicrobials within the first hour of recognition of septic shock (grade 1B) and severe sepsis without septic shock (grade 1C) should be the goal of therapy. Initial empiric anti-infective therapy of one or more drugs that have activity against all likely pathogens and that penetrate in adequate concentrations into tissues presumed to be the source of sepsis (grade 1B). We recommend that empiric antimicrobials be administered within 1 hour of the identification of severe sepsis. Blood cultures should be obtained before administering antibiotics when possible, but this should not delay initiation of antibiotics. The empiric drug choice should be changed as epidemic and endemic ecologies dictate (eg, H1N1, methicillin- resistant S. aureus, chloroquine-resistant malaria, penicillin-resistant pneumococci, recent ICU stay, neutropenia) (grade 1D). We recommend early and aggressive infection source control (grade 1D). We suggest the use of clindamycin and antitoxin therapies for toxic shock syndromes with refractory hypotension (grade 2D). C. difficile colitis should be treated with enteral antibiotics if tolerated. Oral vancomycin is preferred for severe disease (grade 1A). 1 Measure Importance Relationship to Desired Outcome Multiple studies demonstrate reduced mortality and improved outcomes for septic shock patients receiving timely antibiotics in the emergency department. 8,9 In addition, a delay in administration of antibiotics is associated with higher mortality, higher cost, and increased length of in-patient hospital stay. 10 Kumar et al found a 7.6% increase in mortality for every hour hypotensive patients with septic shock experienced a delay of receiving antimicrobials in the Intensive Care Unit. 11 Opportunity for Improvement Clinically, an increase in the duration of hypotension and elevated lactate in the absence of antibiotics in septic shock patients with gram-positive and gram-negative bacteremias has a demonstrated association with poor outcomes and death). 2 There is a mortality benefit with the delivery of anti-infective therapeutic drugs that combat activity against all likely pathogens and presumed sources of septic shock. 2 Results from a multicenter observational study including 15,022 patients from 165 hospitals demonstrated that patients with septic shock were given broad spectrum antibiotics 60.4% in the first quarter of the study. At the final quarter, the increase of compliance on providing antibiotics only increased 7.5% to 67.9%. Clearly, the opportunity to provide comprehensive and timely care to septic shock patients exists. 5 A multi-center randomized controlled trial of early sepsis resuscitation found mortality was significantly increased in patients who received initial antibiotics after septic shock recognition compared with before septic shock recognition. Only 59% of patients received

25 25 Related Measures the initial dose of antibiotics after recognition of septic shock. This demonstrates that delay to antibiotics is harmful and persists. 12 Staff has considered harmonization with CMS Hospital Inpatient Quality Reporting (IQR): Sepsis Bundle and NQF #0500: Severe Sepsis and Septic Shock Management Bundle Measure Designation Type of measure National Quality Strategy Priority/CMS Measure Domain (check all that apply) Level of Measurement (check all that apply) Additional Data Elements Process Outcome Structure Clinical Process-Effectiveness Patient Safety Patient Experience Care Coordination Efficiency: Overuse Efficiency: Cost Population & Community Health Individual clinicians Clinician groups Hospital Outpatient/ED Additional data elements for collection in the American College of Emergency Physician s Clinical Emergency Data Registry (CEDR) are described here. These data elements include: Diagnosis of severe sepsis Diagnosis of organ dysfunction Triage start date and time Provider contact date and time Treatment space date and time Disposition order from ED date and time ICU admission date and time OR admission date and time Antibiotic administration in ED start date and time

26 Data Requirements Table Measure #3: Sepsis Management: Antibiotics Ordered 26 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Supplemental Data Elements Individual Characteristic Patient Characteristic ONC Administrative Sex Administrative Sex (HL7 v2.5) during measurement period Individual Characteristic Patient Characteristic Race CDC during measurement period Individual Characteristic Patient Characteristic Ethnicity CDC during measurement period Individual Characteristic Patient Characteristic Payer Source of Payment Typology during measurement period This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. This data element is collected for the purpose of stratifying results in an effort to highlight disparities. Measure Timing n/a Measurement Period n/a n/a by Measure Implementer Initial Population Individual Characteristic Patient Characteristic Age Calculation n/a Measurement start date minus Birth Date must be greater than or equal to > = 18 years AT Measurement Period 18 years For the purposes of this measure, 'Emergency Department Visit' is defined Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015) Condition/Diagnosis/Problem Diagnosis, Active Infection Condition/Diagnosis/Problem Diagnosis, Active Acute Hypotension Condition/Diagnosis/Problem Diagnosis, Active Sepsis Condition/Diagnosis/Problem Diagnosis, Active Septic Shock Equals Initial Population Transfer of Care Transfer From Inpatient Facility starts before end of [Occurrence A of Encounter, Transfer of Care Transfer From Acute Care Facility starts before end of [Occurrence A of Encounter, Encounter Encounter, Performed Emergency Department Visit, Occurrence A CPT during Measurement Period For the purposes of this measure, 'Emergency Department Visit' is defined as the arrival time through the departure time according to EDBA consensus definitions (Wiler et al. 2015). This attribute is applied to the value set titled 'Emergency Department Visit'. This value set includes the concepts related to 'left against medical advice' and 'left before treatment completion', either with or without an intervention. Exclusions Attribute Attribute: discharge status Left Before Treatment Completion n/a Patient left before treatment completion (LBTC) - Patient left before being seen (LBBS) - Patient left before being seen without intervention (LBBS NI) - Patient left before being seen with intervention (LBBS WI) - Patient left subsequent to being seen (LSBS) (Wiler et al. 2015) Attribute Attribute: discharge status Patient Expired n/a This attribute is applied to the value set titled 'Emergency Department Visit'. Condition/Diagnosis/Problem Diagnosis, Active Cardiac Arrest Intervention Intervention, Order Comfort Measures Intervention Intervention, Performed Comfort Measures American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

27 Data Requirements Table Measure #3: Sepsis Management: Antibiotics Ordered 27 Measure Component QDM* Category QDM* Datatype Value Set Name Standard Terminology OID Constraints Comments/Rationale Communication Communication: Patient to Provider Declined Care Condition/Diagnosis/Problem Diagnosis, Active Burn We seek public comment on the appropriate population of burn patients who should be excluded from this measure. Condition/Diagnosis/Problem Diagnosis, Active Seizure Condition/Diagnosis/Problem Diagnosis, Active Toxicological Emergency This value set includes the concept of metformin toxicity. We seek public comment on what other toxicological emergencies are relevant to these measures and should be included in this value set. Exclusions Condition/Diagnosis/Problem Diagnosis, Active Gastrointestinal Bleeding Condition/Diagnosis/Problem Diagnosis, Active Stroke Condition/Diagnosis/Problem Diagnosis, Active Myocardial Infarction Condition/Diagnosis/Problem Diagnosis, Active Acute Trauma Attribute Attribute: Ordinality Principal n/a This attribute determines that a diagnosis was the principal diagnosis for the 'Emergency Department Visit' and is applied to the value sets titled 'Gastrointestinal Bleeding', 'Stroke', 'Myocardial Infarction', and 'Acute Trauma'. Numerator Medication Medication, Order IV Antibiotics for Sepsis RxNorm during [Occurrence A of Encounter, Performed: Exceptions There are no valid denominator exceptions 2015 American College of Emergency Physicians. All Rights Reserved. Quality Data Model (QDM), Version 4.1.2

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting ACEP19 Emergency Department Utilization of CT for Minor Blunt Head Trauma for Aged 18 Years and Older Percentage of visits for aged 18 years and older who presented with a minor blunt head trauma who had

More information

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) National Quality Strategy

More information

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) National Quality Strategy

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

Preventive Care and Screening: Influenza Immunization

Preventive Care and Screening: Influenza Immunization e Title e Identifier ( Authoring Tool) Preventive Care and Screening: Influenza Immunization 147 e Version number 6.1.000 NQF Number 0041 GUID a244aa29-7d11-4616-888a-86e376bfcc6f ment Period Steward Developer

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2018

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure. #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2017

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #143 (NQF 0384): Oncology: Medical and Radiation Pain Intensity Quantified National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction Measure #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination Measure #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process This is a two-part

More information

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40% Quality ID #118 (NQF 0066): Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction

More information

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

DESCRIPTION: Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication

DESCRIPTION: Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication Measure #53 (NQF 0047): Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-7 (NQF 0041): Preventive Care and Screening: Influenza Immunization Measure Steward: PCPI CMS Web Interface V2.1 Page 1 of 19 06/25/ Contents INTRODUCTION... 3 CMS WEB INTERFACE

More information

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care

Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care Measure #72 (NQF 0385): Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY

More information

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period Quality ID #431 (NQF 2152): Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling - National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL

More information

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

This is a two-part measure which is paired with Measure #154: Falls: Risk Assessment.

This is a two-part measure which is paired with Measure #154: Falls: Risk Assessment. Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination Meaningful Measure Area: Preventable Healthcare Harm 2019 COLLECTION TYPE: MEDICARE

More information

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period Quality ID #387 (NQF 3060): Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #102 (NQF 0389): Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #325: Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid Conditions National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-7 (NQF 0041): Preventive Care and Screening: Influenza Immunization Measure Steward: PCPI CMS Web Interface V2.0 Page 1 of 19 11/13/2017 Contents INTRODUCTION... 3 CMS WEB INTERFACE

More information

Quality ID #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

Quality ID #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety Quality ID #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade Measure #99 (NQF 0391): Breast Cancer Resection Pathology Reporting: pt Category (Primary Tumor) and pn Category (Regional Lymph Nodes) with Histologic Grade National Quality Strategy Domain: Effective

More information

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #334: Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency Measure #334: Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse) National Quality Strategy Domain: Efficiency and Cost Reduction 2017 OPTIONS

More information

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy National Quality Strategy Domain: Effective Clinical

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority Quality ID #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Preventable Healthcare Harm

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis Quality ID #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency Quality ID #333: Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period Quality ID #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR

More information

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320 Quality ID #147: Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS

More information

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Percentage of new patients whose

More information

Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process This is a two-part measure which

More information

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow Quality ID #67 (NQF 0377): Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow National Quality Strategy Domain: Effective Clinical Care

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic

More information

Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Percentage

More information

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

emeasure Title emeasure Identifier (Measure Authoring Tool) 621 emeasure Version number

emeasure Title emeasure Identifier (Measure Authoring Tool) 621 emeasure Version number emeasure Title emeasure Identifier (Measure Authoring Tool) Measurement That Matters 621 emeasure Version number 0.0.013 NQF Number GUID a81691e2-4be1-4725-b279- a07448a74bcd Measurement Period Measure

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #400 (NQF 3059): One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis Quality ID #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Preventive Care

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #22 (NQF 0271): Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Non-Cardiac Procedures) National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Quality ID #224 (NQF 0562): Melanoma: Overutilization of Imaging Studies in Melanoma National Quality Strategy Domain: Efficiency and Cost Reduction

Quality ID #224 (NQF 0562): Melanoma: Overutilization of Imaging Studies in Melanoma National Quality Strategy Domain: Efficiency and Cost Reduction Quality ID #224 (NQF 0562): Melanoma: Overutilization of Imaging Studies in Melanoma National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity National Quality Strategy Domain: Effective Clinical Care Measure Meaningful Measure Area: Management of Chronic Conditions

More information

Measure #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

Measure #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety Measure #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Measure #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS F

More information

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage of

More information

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #104 (NQF 0390): Prostate Cancer: Adjuvant Hormonal Therapy for High Risk or Very High Risk Prostate Cancer National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage of

More information

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority Quality ID #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety Meaningful Measure Area: Admissions and Readmissions to Hospitals 2019 COLLECTION

More information

**Please read the DQA Measures User Guide prior to implementing this measure.**

**Please read the DQA Measures User Guide prior to implementing this measure.** **Please read the DQA Measures User Guide prior to implementing this measure.** DQA Measure Technical Specifications: Administrative Claims-Based Measures Prevention: Topical Fluoride for Children at Elevated

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time Pathologist to Clinician National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS

More information

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA Quality ID #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

DENOMINATOR: All patients, regardless of age, with a diagnosis of inflammatory bowel disease who initiated an anti-tnf agent

DENOMINATOR: All patients, regardless of age, with a diagnosis of inflammatory bowel disease who initiated an anti-tnf agent Quality ID #275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy National Quality Strategy Domain: Effective Clinical

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #277: Sleep Apnea: Severity Assessment at Initial Diagnosis National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

Measure #279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy National Quality Strategy Domain: Effective Clinical Care

Measure #279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy National Quality Strategy Domain: Effective Clinical Care Measure #279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE:

More information

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a

More information

Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care

Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome

More information

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention, Treatment, and Management of Mental Health 2019 COLLECTION

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #364: Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines National Quality

More information

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: All patients

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #104 (NQF 0390): Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #205 (NQF 0409): HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome Quality ID #328 (NQF 1667): Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dl National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

Quality ID #39 (NQF 0046): Screening for Osteoporosis for Women Aged Years of Age National Quality Strategy Domain: Effective Clinical Care

Quality ID #39 (NQF 0046): Screening for Osteoporosis for Women Aged Years of Age National Quality Strategy Domain: Effective Clinical Care Quality ID #39 (NQF 0046): Screening for Osteoporosis for Women Aged 65-85 Years of Age National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority Quality ID #463: Prevention of Post-Operative Vomiting (POV) Combination Therapy (Pediatrics) National Quality Strategy Domain: Patient Safety Meaningful Measure Area: Preventive Care 2019 COLLECTION TYPE:

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #179: Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Quality ID #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS F INDIVIDUAL

More information

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE

More information

Measure #286: Dementia: Counseling Regarding Safety Concerns National Quality Strategy Domain: Patient Safety

Measure #286: Dementia: Counseling Regarding Safety Concerns National Quality Strategy Domain: Patient Safety Measure #286: Dementia: Counseling Regarding Safety Concerns National Quality Strategy Domain: Patient Safety 2017 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

Measure #156 (NQF 0382): Oncology: Radiation Dose Limits to Normal Tissues National Quality Strategy Domain: Patient Safety

Measure #156 (NQF 0382): Oncology: Radiation Dose Limits to Normal Tissues National Quality Strategy Domain: Patient Safety Measure #156 (NQF 0382): Oncology: Radiation Dose Limits to Normal Tissues National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care

Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care Measure #250 (NQF 1853): Radical Prostatectomy Pathology Reporting National Quality Strategy Domain: Effective Clincial Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

emeasure Version number 0

emeasure Version number 0 emeasure Title Example emeasure Identifier (Measure Authoring Tool) emeasure Version number 0 NQF Number GUID x Measurement Period Measure Steward Measure Developer Endorsed By Description Copyright Disclaimer

More information

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented emeasure Title Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented emeasure Identifier (Measure Authoring Tool) 22 emeasure Version number 5.1.000 NQF Number Not Applicable

More information